Lucy Therapeutics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Out of Business

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Out of Business

Lucy Therapeutics General Information

Description

Developer of proprietary mitochondrial-based small molecule therapies and diagnostic biomarkers designed for the central nervous system. The company offers genetic technologies providing unparalleled insights into personalized medicine and improving patient outcomes, enabling the healthcare industry to harness the power of genomics for precise healthcare interventions and better overall well-being.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 21 Hickory Drive
  • Suite 2B
  • Waltham, MA 02451
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 21 Hickory Drive
  • Suite 2B
  • Waltham, MA 02451
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lucy Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Out of Business 01-Jun-2025 Completed Out of Business
9. Later Stage VC (Series A3) 28-May-2024 Completed Pre-Clinical Trials
8. Grant 11-Apr-2022 Completed Pre-Clinical Trials
7. Later Stage VC (Series A) 06-Jan-2022 Completed Pre-Clinical Trials
6. Accelerator/Incubator 01-Jan-2021 Completed Startup
5. Accelerator/Incubator 09-Oct-2020 Completed Startup
4. Seed Round 24-Jul-2020 Completed Startup
3. Accelerator/Incubator 01-Jan-2020 Completed Startup
2. Grant 19-Jun-2019 $87.5K Completed Startup
1. Accelerator/Incubator Completed Startup
To view Lucy Therapeutics’s complete valuation and funding history, request access »

Lucy Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-3
Series A-2
Series A-1 8,805,028 $0.000100 $1.59 $1.59 1x $1.59 31.11%
Seed 3,866,244 $0.000100 $1.17 $1.17 1x $1.17 13.66%
To view Lucy Therapeutics’s complete cap table history, request access »

Lucy Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of proprietary mitochondrial-based small molecule therapies and diagnostic biomarkers designed for the central
Drug Discovery
Waltham, MA
12 As of 2025

New York, NY
 

Clarksville, MD
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Lucy Therapeutics Competitors (2)

One of Lucy Therapeutics’s 2 competitors is Brainstorm Cell Therapeutics, a Corporation company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Brainstorm Cell Therapeutics Corporation New York, NY
NeuroNascent Venture Capital-Backed Clarksville, MD
You’re viewing 2 of 2 competitors. Get the full list »

Lucy Therapeutics Patents

Lucy Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026024795-A1 F-atp hydrolase inhibitors Pending 24-Jul-2024
WO-2026024812-A1 F-atp hydrolase inhibitors Pending 24-Jul-2024
WO-2025038781-A1 Adenosine ligands for the treatment of neurological disorders or chronic heart failure Inactive 15-Aug-2023
WO-2025038782-A1 Adenosine ligands for the treatment of neurological disorders or chronic heart failure Inactive 15-Aug-2023
WO-2025038783-A1 Adenosine ligands for the treatment of neurological disorders or chronic heart failure Inactive 15-Aug-2023 A61K31/444
To view Lucy Therapeutics’s complete patent history, request access »

Lucy Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lucy Therapeutics FAQs

  • When was Lucy Therapeutics founded?

    Lucy Therapeutics was founded in 2017.

  • Where is Lucy Therapeutics headquartered?

    Lucy Therapeutics is headquartered in Waltham, MA.

  • What is the size of Lucy Therapeutics?

    Lucy Therapeutics has 12 total employees.

  • What industry is Lucy Therapeutics in?

    Lucy Therapeutics’s primary industry is Drug Discovery.

  • Is Lucy Therapeutics a private or public company?

    Lucy Therapeutics is a Private company.

  • What is Lucy Therapeutics’s current revenue?

    The current revenue for Lucy Therapeutics is .

  • How much funding has Lucy Therapeutics raised over time?

    Lucy Therapeutics has raised $42.3M.

  • Who are Lucy Therapeutics’s competitors?

    Brainstorm Cell Therapeutics and NeuroNascent are competitors of Lucy Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process